Company Biondvax Pharmaceuticals Ltd
Equities
IL0011052045
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- ILa | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 49 | 01/03/21 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 31/12/06 |
Chief Tech/Sci/R&D Officer | - | 31/12/21 | |
Shai Ashkenazi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Elad Mark
COO | Chief Operating Officer | 42 | 31/12/17 |
Shimon Hassin
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 31/12/03 | |
Investor Relations Contact | - | 30/11/15 | |
Human Resources Officer | - | 31/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adi Raviv
BRD | Director/Board Member | 69 | 23/03/20 |
Samuel Moed
BRD | Director/Board Member | 62 | 23/03/20 |
Morris Laster
BRD | Director/Board Member | 60 | 26/11/17 |
Mark Germain
CHM | Chairman | 75 | 27/06/18 |
Yael Margolin
BRD | Director/Board Member | 70 | 31/12/18 |
Avner Rotman
BRD | Director/Board Member | 80 | 26/03/05 |
Amir Reichman
CEO | Chief Executive Officer | 49 | 01/03/21 |
Jay Green
BRD | Director/Board Member | 52 | 26/12/21 |
Company contact information
Scinai Immunotherapeutics Ltd.
Jerusalem BioPark Hadassah Ein Kerem Campus
74036, Jerusalem
+972 8 930 2529
http://www.biondvax.comSector
1st Jan change | Capi. | |
---|---|---|
+21.79% | 46.81B | |
-0.85% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.03% | 26.06B | |
-19.04% | 19.13B | |
+32.17% | 12.39B | |
+0.32% | 12.08B | |
+0.32% | 11.96B |
- Stock Market
- Equities
- Stock
- Company Biondvax Pharmaceuticals Ltd